Lynx1 Capital Management LP - 08 Oct 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CGEM
Shares outstanding: 59M shares
Disclosed Ownership: 8.55M shares
Ownership: 14.5%
Form type: SCHEDULE 13G/A
Filing time: 10 Oct 2025, 18:53:20 UTC
Date of event: 08 Oct 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	14.5%	8.55M	0	8.55M	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	14.5%	8.55M	0	8.55M	/s/ Weston Nichols	Weston Nichols, Individually